How do we know when the last participant in cohort 4 received their last dose?
Then there will need to be testing and assessments at the completion for each participant?
Once all the results have been received and assessments completed they will need to get the analysis of each set of data?
Who would be writing the final report, the new CEO?
I think it could take a bit of time to complete and might not be just pushing a button once the final participant completes dosing, we might not see the phase 1/2 final report till next month possibly?
How do we know when the last participant in cohort 4 received...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |